Oasmia Pharmaceutical AB Volatility
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
We have found seventeen technical indicators for Oasmia Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Oasmia Pharmaceutical's Risk Adjusted Performance of 0.0118, coefficient of variation of 35042.85, and Variance of 568.28 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Oasmia Pharmaceutical's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Oasmia Pharmaceutical Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Oasmia daily returns, and it is calculated using variance and standard deviation. We also use Oasmia's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Oasmia Pharmaceutical volatility.
Oasmia |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Oasmia Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Oasmia Pharmaceutical at lower prices. For example, an investor can purchase Oasmia stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Oasmia Pharmaceutical's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Oasmia Pink Sheet
| 0.61 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.52 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.49 | VAXX | Vaxxinity | PairCorr |
| 0.48 | VASO | Vaso Corp | PairCorr |
| 0.46 | ENZN | Enzon Pharmaceuticals | PairCorr |
Oasmia Pharmaceutical Market Sensitivity And Downside Risk
Oasmia Pharmaceutical's beta coefficient measures the volatility of Oasmia pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Oasmia pink sheet's returns against your selected market. In other words, Oasmia Pharmaceutical's beta of 3.6 provides an investor with an approximation of how much risk Oasmia Pharmaceutical pink sheet can potentially add to one of your existing portfolios. Oasmia Pharmaceutical AB is displaying above-average volatility over the selected time horizon. Oasmia Pharmaceutical AB is a penny stock. Although Oasmia Pharmaceutical may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Oasmia Pharmaceutical AB. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Oasmia instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Oasmia Pharmaceutical Demand TrendCheck current 90 days Oasmia Pharmaceutical correlation with market (Dow Jones Industrial)Oasmia Beta |
Oasmia standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Oasmia Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Oasmia Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in oasmia pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Oasmia Pharmaceutical.
Oasmia Pharmaceutical Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Oasmia Pharmaceutical pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Oasmia Pharmaceutical's price changes. Investors will then calculate the volatility of Oasmia Pharmaceutical's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Oasmia Pharmaceutical's volatility:
Historical Volatility
This type of pink sheet volatility measures Oasmia Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict Oasmia Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Oasmia Pharmaceutical's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Oasmia Pharmaceutical's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Oasmia Pharmaceutical Projected Return Density Against Market
Assuming the 90 days horizon the pink sheet has the beta coefficient of 3.5996 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Oasmia Pharmaceutical will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oasmia Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oasmia Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oasmia pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Oasmia Pharmaceutical AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives an Oasmia Pharmaceutical Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Oasmia Pharmaceutical Pink Sheet Return Volatility
Oasmia Pharmaceutical historical daily return volatility represents how much of Oasmia Pharmaceutical pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 0.0% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7356% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Oasmia Pharmaceutical Volatility
Volatility is a rate at which the price of Oasmia Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Oasmia Pharmaceutical may increase or decrease. In other words, similar to Oasmia's beta indicator, it measures the risk of Oasmia Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Oasmia Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Vivesto Ab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 17 people.
Oasmia Pharmaceutical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Oasmia Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Oasmia Pharmaceutical's price varies over time.
3 ways to utilize Oasmia Pharmaceutical's volatility to invest better
Higher Oasmia Pharmaceutical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Oasmia Pharmaceutical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Oasmia Pharmaceutical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Oasmia Pharmaceutical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Oasmia Pharmaceutical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Oasmia Pharmaceutical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Oasmia Pharmaceutical Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.74 and is 9.223372036854776E16 times more volatile than Oasmia Pharmaceutical AB. 0 percent of all equities and portfolios are less risky than Oasmia Pharmaceutical. You can use Oasmia Pharmaceutical AB to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Oasmia Pharmaceutical to be traded at $0.0594 in 90 days.Significant diversification
The correlation between Oasmia Pharmaceutical AB and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and DJI in the same portfolio, assuming nothing else is changed.
Oasmia Pharmaceutical Additional Risk Indicators
The analysis of Oasmia Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Oasmia Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of Oasmia Pharmaceutical pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0118 | |||
| Market Risk Adjusted Performance | 0.0261 | |||
| Mean Deviation | 5.71 | |||
| Coefficient Of Variation | 35042.85 | |||
| Standard Deviation | 23.84 | |||
| Variance | 568.28 | |||
| Information Ratio | (0.0007) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Oasmia Pharmaceutical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Oasmia Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Oasmia Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Oasmia Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Oasmia Pharmaceutical AB.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |